Cardiovascular drugs and therapy · 2002
Effects of canrenone on myocardial reactive fibrosis in a rat model of postinfarction heart failure.
Сравнительное исследованиеСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Cittadini Antonio, Casaburi Cosma, Monti Maria Gaia, Di Gianni Angela, Serpico Raffaella, Scherillo Giovanna, Saldamarco Lavinia, Vanasia Massimo, Saccà Luigi
Аннотация
BACKGROUND: Spironolactone reduces overall mortality by 30% in advanced congestive heart failure. Nevertheless, few data are available with regard to the effects of mineral corticoid inhibition in postinfarction heart failure.
MATERIALS AND METHODS: Experimental myocardial infarction was induced by left coronary ligation in 70 male rats with body weights ranging from 180 to 200 gr. The day after surgery, animals were randomized to either placebo or canrenone-gamma-cyclodestrin 8 mg/kg/die or canrenone-gamma-cyclodestrin 18 mg/kg/die. Twelve animals served as the control group. After two weeks, the rats underwent closed chest left ventricular catheterization. The heart was the rapidly excised for subsequent histological analysis.
RESULTS: Compared with controls, infarcted rats had reduced left ventricular systolic pressures (-6%) and higher left ventricular end-diastolic pressures (+600%), associated with a marked increase of mean collagen fraction (+446%) and perivascular fibrosis (+72%). Compared with placebo-infarcted rats, in the group treated with high canrenone dose there was a significant reduction of left ventricular systolic and end-diastolic pressures (-6.5% and -23%, respectively) and an attenuation of interstitial and perivascular fibrosis (-47% and -34%, respectively). The low-dose canrenone group did not show differences compared with the placebo infarcted rats, except for a slight reduction of mean collagen fraction (-21%).
CONCLUSIONS: Canrenone attenuates LV interstitial remodeling and reduces filling pressures in rats with postinfarction heart failure.
MATERIALS AND METHODS: Experimental myocardial infarction was induced by left coronary ligation in 70 male rats with body weights ranging from 180 to 200 gr. The day after surgery, animals were randomized to either placebo or canrenone-gamma-cyclodestrin 8 mg/kg/die or canrenone-gamma-cyclodestrin 18 mg/kg/die. Twelve animals served as the control group. After two weeks, the rats underwent closed chest left ventricular catheterization. The heart was the rapidly excised for subsequent histological analysis.
RESULTS: Compared with controls, infarcted rats had reduced left ventricular systolic pressures (-6%) and higher left ventricular end-diastolic pressures (+600%), associated with a marked increase of mean collagen fraction (+446%) and perivascular fibrosis (+72%). Compared with placebo-infarcted rats, in the group treated with high canrenone dose there was a significant reduction of left ventricular systolic and end-diastolic pressures (-6.5% and -23%, respectively) and an attenuation of interstitial and perivascular fibrosis (-47% and -34%, respectively). The low-dose canrenone group did not show differences compared with the placebo infarcted rats, except for a slight reduction of mean collagen fraction (-21%).
CONCLUSIONS: Canrenone attenuates LV interstitial remodeling and reduces filling pressures in rats with postinfarction heart failure.
Предметные рубрики MeSH
Administration, OralAldosteroneAnimalsCanrenoneCollagenCyclodextrinsDisease Models, AnimalDose-Response Relationship, DrugEndomyocardial FibrosisHeart FailureHemodynamicsHydroxyprolineMaleMineralocorticoid Receptor AntagonistsMyocardial InfarctionMyocardiumRatsRats, Sprague-DawleyVentricular Function, Leftgamma-Cyclodextrins